Compare ITRM & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITRM | WAL |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | Ireland | United States |
| Employees | N/A | 3524 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 9.6B |
| IPO Year | 2018 | N/A |
| Metric | ITRM | WAL |
|---|---|---|
| Price | $0.17 | $80.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | $9.00 | ★ $101.40 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | ★ 57.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.16 |
| Revenue Next Year | $947.65 | $8.63 |
| P/E Ratio | ★ N/A | $10.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $57.05 |
| 52 Week High | $1.49 | $97.23 |
| Indicator | ITRM | WAL |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 36.61 |
| Support Level | N/A | $70.53 |
| Resistance Level | $0.39 | $82.37 |
| Average True Range (ATR) | 0.04 | 3.57 |
| MACD | -0.01 | -1.47 |
| Stochastic Oscillator | 15.94 | 17.23 |
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.